Schrödinger
North America, New York, United States, New York
Description
Schrödinger is a healthcare-based software company that develops molecular design software for biotech and materials research.
Investor Profile
Schrödinger has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Seed (33%)
- Series C (22%)
- Series B (22%)
- Series A (11%)
- Series Unknown (11%)
Country Focus
- United States (89%)
- Canada (11%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Life Science
- Pharmaceutical
- Product Research
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
